Rheumatoid arthritis in smokers could be linked to Proteus urinary tract infections

Medical Hypotheses

Volumn 70, Issue 5, 2008, Pages 975-980

  Rashid, Taha ^a   Ebringer, Alan ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HLA ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CROSS REACTION; CYTOTOXICITY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEUS; RHEUMATOID ARTHRITIS; SEROLOGY; SMOKING; URINARY TRACT INFECTION;

ALLELES; ARTHRITIS, RHEUMATOID; COMORBIDITY; DISEASE SUSCEPTIBILITY; EPITOPES; HUMANS; IMMUNE SYSTEM; MODELS, BIOLOGICAL; MODELS, THEORETICAL; PROTEUS; PROTEUS INFECTIONS; SMOKING; URINARY TRACT INFECTIONS;

EID: 40849141362     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.08.026     Document Type: Article

References (45)

1. Spector T.D. Epidemiology of rheumatic diseases: rheumatoid arthritis. Rheum Dis Clin North Am 16 (1990) 513-537
2. Cooper N.J. Economic burden of rheumatoid arthritis: a systematic review. Rheumatology 39 (2000) 28-33
3. Eberhardt K., Larsson B.M., Nived K., and Lindqvist E. Work disability in rheumatoid arthritis - development over 15 years and evaluation of predictive factors over time. J Rheumatol 34 (2007) 481-487
4. Shatin R. The epidemiology of rheumatoid arthritis and human ecology. Acta Rheumatol Scand 11 (1965) 161-168
5. Stastny P. Mixed lymphocyte cultures in rheumatoid arthritis. J Clin Invest 57 (1976) 1148-1157
6. Watanabe Y., Tokunaga K., Matsuki K., et al. Putative amino acid sequence of HLA-DRß chain contributing to rheumatoid arthritis susceptibility. J Exp Med 169 (1989) 2263-2268
7. Gregersen P.K., Silver J., and Winchester R.J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30 (1987) 1205-1213
8. Weyand C.M., Hicok K.C., Conn D.L., and Goronzy J.J. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 117 (1992) 801-806
9. Silman A.J., MacGregor A.J., Thomson W., et al. Twin concordance rates for rheumatoid arthritis: results from a nation-wide study. Br J Rheumatol 32 (1993) 9037
10. Maini R.N., and Feldmann M. Immunopathogenesis of rheumatoid arthritis. In: Isenberg D.A., Maddison P.J., Woo P., Glass D.N., and Breedveld F.C. (Eds). Oxford Textbook of Rheumatology (2004), Oxford University Press, Oxford 677-696
11. Vessey M.P., Villard-Mackintosh L., and Yeates D. Oral contraceptives, cigarette smoking and other factors in relation to arthritis. Contraception 35 (1987) 457-464
12. Klareskog L., Padyukov L., and Alfredsson L. Smoking as a trigger for inflammatory rheumatic diseases. Curr Opin Rheumatol 19 (2007) 49-54
13. Manfredsdottir V.F., Vikingsdottir T., Jonsson T., et al. The effect of tobacco smoking and rheumatoid factor seropositivity on disease activity and joint damage in early rheumatoid arthritis. Rheumatology 45 (2006) 734-740
14. Costenbader K.H., Feskanich D., Mandl L.A., and Karlson E.W. Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women. Am J Med 119 (2006) 503.e1-9
15. Doll R., Peto R., Wheatley K., Gray R., and Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. Br Med J 309 (1994) 901-911
16. Nymand G. Maternal smoking and immunity. Lancet ii (1974) 1379-1380
17. Boyce A., Schwartz D., and David G. Smoking and genitourinary infection. Br Med J 2 (1976) 1013
18. Dales L.G., Friedman G., Siegelaub A.B., Seltzer C.C., and Ury H.K. Cigarette smoking habits and urine characteristics: urinalysis abnormalities are more common in smokers, but the reasons are unclear. Nephron 20 (1978) 167-170
19. George J., Levy Y., and Shoenfeld Y. Smoking and immunity: an additional player in the mosaic of autoimmunity. Scand J Immunol 45 (1997) 1-6
20. Barton J.R., Riad M.A., Gaze M.N., Maran A.G., and Ferguson A. Mucosal immunodeficiency in smokers, and in patients with epithelial head and neck tumours. Gut 31 (1990) 378-382
21. Yamaguchi E., Itoh A., Furuya K., et al. Release of tumor necrosis factor α from human alveolar macrophages is decreased in smokers. Chest 103 (1993) 479-483
22. Ebringer A, Wilson C, Ahmadi K et al. Rheumatoid arthritis as a reactive arthritis to Proteus infection: Prospects for therapy. In: Machtey I, editor. "Sixth International Seminar on the Treatment of Rheumatic Diseases". Prog Rheumatol 1993;5:7783.
23. Senior B.W., Anderson G.A., Morley K.D., and Kerr M.A. Evidence that patients with rheumatoid arthritis have asymptomatic (non-significant' Proteus mirabilis bacteriuria more frequently than healthy controls. J Infect 38 (1999) 99-106
24. Wilson C., Thakore D., Isenberg D., and Ebringer A. Correlation between anti-Proteus antibodies and isolation rates of P. mirabilis in rheumatoid arthritis. Rheumatol Int 16 (1997) 1879
25. Ebringer A., Rashid T., and Wilson C. Rheumatoid arthritis: proposal for the use of anti-microbial therapy in early cases. Scand J Rheumatol 32 (2003) 2-11
26. Newkirk M.M., Goldbach-Mansky R., Senior B.W., Klippel J., Schumacher Jr. H.R., and El-Gabalawy H.S. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis. Rheumatology 44 (2005) 1433-1441
27. Rashid T., and Ebringer A. Rheumatoid arthritis is linked to Proteus - the evidence. Clin Rheumatol 26 (2007) 1036-1043
28. Rashid T., Ebringer A., Wilson C., Bansal S., Paimela L., and Binder A. The potential use of antibacterial peptide antibody indices in the diagnosis of rheumatoid arthritis and ankylosing spondylitis. J Clin Rheumatol 12 (2006) 11-16
29. Ebringer A., Cunningham P., Ahmadi K., Wrigglesworth J., Hosseini R., and Wilson C. Sequence similarity between HLA-DR1 and DR4 subtypes associated with rheumatoid arthritis and Proteus/Serratia membrane haemolysins. Ann Rheum Dis 51 (1992) 1245-1246
30. Wilson C., Ebringer A., Ahmadi K., et al. Shared amino acid sequences between major histocompatibility complex class II glycoproteins, type XI collagen and Proteus mirabilis in rheumatoid arthritis. Ann Rheum Dis 54 (1995) 216-220
31. Ebringer A., Ptaszynska T., Corbett M., et al. Antibodies to Proteus in rheumatoid arthritis. Lancet ii (1985) 305-307
32. Tiwana H., Wilson C., Alvarez A., Abuknesha R., Bansal S., and Ebringer A. Cross-reactivity between the rheumatoid arthritis-associated motif EQKRAA and structurally related sequences found in Proteus mirabilis. Infect Immun 67 (1999) 2769-2775
33. Wilson C., Rashid T., Tiwana H., et al. Cytotoxicity responses to peptide antigens in rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 30 (2003) 972-978
34. Lawson A.A., and Maclean N. Renal disease and drug therapy in rheumatoid arthritis. Ann Rheum Dis 25 (1966) 4419
35. Tishler M., Caspi D., Aimog Y., Segal R., and Yaron M. Increased incidence of urinary tract infection in patients with rheumatoid arthritis and secondary Sjogren's syndrome. Ann Rheum Dis 51 (1992) 6016
36. Ebringer A., and Rashid T. Rheumatoid arthritis is an autoimmune disease triggered by Proteus urinary tract infection. Clin Dev Immunol 13 (2006) 41-48
37. Gorman J.D. Smoking and rheumatoid arthritis: another reason to just say no. Arthritis Rheum 54 (2006) 10-13
38. Van der Helm-van Mil A.H., Verpoort K.N., le Cessie S., Huizinga T.W., de Vries R.R., and Toes R.E. The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide. Arthritis Rheum 56 (2007) 425-432
39. Papadoupolos N.G., Alamanos Y., Voulgari P.V., Epagelis E.K., Tsifetaki N., and Drosos A.A. Does cigarette smoking influence disease expression, activity and severity in early rheumatoid arthritis patients?. Clin Exp Rheumatol 23 (2005) 861-866
40. Kuek A., Hazleman B.L., and Ostor A.J. Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgrad Med J 83 (2007) 251-260
41. Kavanaugh A. Economic issues with new rheumatologic therapeutics. Curr Opin Rheumatol 19 (2007) 272-276
42. Wilson C., Senior B.W., Tiwana H., Caparros-Wanderley W., and Ebringer A. Antibiotic sensitivity and proticine typing of Proteus mirabilis strains associated with rheumatoid arthritis. Rheumatol Int 17 (1998) 2035
43. Kjeldsen-Kragh J., Rashid T., Dybwad A., et al. Decrease in anti-Proteus mirabilis but not anti-Escherichia coli antibody levels in rheumatoid arthritis patients treated with fasting and a one year vegetarian diet. Ann Rheum Dis 54 (1995) 2214
44. Rashid T., Tiwana H., Wilson C., and Ebringer A. Rheumatoid arthritis as an autoimmune disease caused by Proteus urinary tract infections: a proposal for a therapeutic protocol. IMAJ 3 (2001) 675-680
45. Combe B. Early rheumatoid arthritis: strategies for prevention and management. Best Pract Res Clin Rheumatol 21 (2007) 27-42